[1]
M. PADMASREE and B. A. VISHWANATH, “DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED CAPECITABINE LIPOSOMAL FORMULATIONS WITH ANTICANCER ACTIVITY TOWARDS COLON CANCER”, Int J App Pharm, vol. 14, no. 2, pp. 135–142, Mar. 2022.